Salmonella Vaccine
Recombinant Salmonella vaccines for biodefense are subject of review
Published in Bioterrorism Week, June 19th, 2006
According to a report from England, "There is a requirement for vaccines to protect against pathogens that may be misused for bioterrorism or biowarfare purposes. In particular, biodefense vaccines are required that may be used for safe and easy immunization of populations and that can rapidly induce mucosal immunity to provide protection at the lung surface against a range of airborne agents."
"To address this need, recombinant Salmonella vaccines are being developed," said Helen S. Atkins and colleagues at the Defense Science and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Bioterrorism Week
Source: Bioterrorism Week (2006-06-19)
More Articles from Bioterrorism Week
- Anthrax Vaccine
Informed consent policy for anthrax vaccination in U.K. armed forces increases safety concerns - Avian Influenza
United Nations requests supplies of DuPont's veterinary disinfectant to help control avian flu - Botulism Antitoxin
U.S. Department of Health and Human Services awards BioShield contract for botulism antitoxin - Business Update
Chimerix acquires lead compound library of antiviral agents from University of Michigan - Business Update
CombiMatrix announces contract with Northrop Grumman Corporation - Food Safety
Array biosensor detects the mycotoxin deoxynivalenol in foods and indoor air - More from this issue of Bioterrorism Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
